Roncoleukin - immunostimulant high antitumor activity.
Pharmacological action Roncoleukin
Roncoleukin, acting as an immunostimulant, enhances the antiviral, antibacterial, antifungal and anti-tumor immune response.
Active ingredient Roncoleukin - interleukin-2 plays an important role in development of the immune response, and has an effect on the various components of the immune system.
Treatment Roncoleukin provides protection that is directed not only against tumor cells, but also against the pathogens of bacterial, viral and fungal infections.
Release form and composition
Roncoleukin dosage forms are:
- The solution was a light yellow color for intravenous or subcutaneous administration, containing in 1 ml 100, 250, 500 or 1000 micrograms of recombinant human interleukin-2. In 1 ml ampoules;
- Valium for solution for infusion in vials.
Analogues Roncoleukin mode of action are Betaleukin drugs, Proleukin in a dosage form of a lyophilisate for solution.
Roncoleukin used in the treatment of kidney cancer in adults and for the correction of secondary immunodeficiency after surgery.
Furthermore, a solution Roncoleukin prescribed for adults in conjunction with other drugs in the treatment of various sepsis accompanied immunosuppression. Roncoleukin Review is used in the following types of sepsis:
Also installed Roncoleukin efficiency to compensate and prevent immunodeficiencies at:
- HIV infection;
- Cytomegalovirus infection;
- Secondary infertility;
- Purulent sinusitis;
- Diabetic Foot;
- Hepatitis C;
According to the instructions Roncoleukin contraindicated appoint:
- Autoimmune diseases;
- Severe diseases of the cardiovascular system;
- Hypersensitivity to yeast, interleukin-2 and other components of the solution.
Instructions for Roncoleukin administered once a day intravenously or subcutaneously. Average dose - 2 mg.
When surgical, post-traumatic, obstetric and gynecological, wound, burn, and other forms of sepsis treatment Roncoleukin conducted over 1-10 days. With intervals of 1-3 days 0, 5-1 mg of the solution is administered one to three times.
When kidney cancer Roncoleukin administered before surgery a single dose of 500 micrograms or include in the course of two months immunochemotherapy.
According to the instructions Roncoleukin compatible with all drugs.
Most often Roncoleukin Review does not cause side effects.
In rare cases, the process of introducing Roncoleukin Review may receive intermittent fever or rise in body temperature. These symptoms are not grounds for termination of treatment, and therapeutic agents to easily cropped.
Roncoleukin refers to a number of antitumor drugs List B. The shelf life of the drug, subject to temperature in the range of 2-8 ° C is 24 months.